Search by Drug Name or NDC
NDC 10702-0001-09 LOMAIRA 8 mg/1 Details
LOMAIRA 8 mg/1
LOMAIRA is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by KVK-TECH, INC.. The primary component is PHENTERMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phentermine is used for a limited period of time to speed weight loss in overweight people who are exercising and eating a low-calorie diet. Phentermine is in a class of medications called anorectics. It works by decreasing appetite.
Related Packages: 10702-0001-09Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Phentermine
Product Information
| NDC | 10702-0001 |
|---|---|
| Product ID | 10702-001_0ce01306-ef7f-563f-e063-6394a90a52b7 |
| Associated GPIs | 61200070100305 |
| GCN Sequence Number | 005160 |
| GCN Sequence Number Description | phentermine HCl TABLET 8 MG ORAL |
| HIC3 | J8A |
| HIC3 Description | ANTI-OBESITY - ANOREXIC AGENTS |
| GCN | 20715 |
| HICL Sequence Number | 002111 |
| HICL Sequence Number Description | PHENTERMINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | LOMAIRA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Phentermine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENTERMINE HYDROCHLORIDE |
| Labeler Name | KVK-TECH, INC. |
| Pharmaceutical Class | Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA203495 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10702-0001-09 (10702000109)
| NDC Package Code | 10702-001-09 |
|---|---|
| Billing NDC | 10702000109 |
| Package | 90 TABLET in 1 BOTTLE (10702-001-09) |
| Marketing Start Date | 2016-09-12 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.54635 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | LOMAIRA 8 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis